EGFR
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
EGFR
Jun 29, 2024, 07:45 |
Insight
Katsuaki Maehara: The changes in TME and TKI treatment resistance by EGFR and ALK TKI
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X: …
Jun 26, 2024, 12:40 |
Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 25, 2024, 13:50 |
Blog
Roy Herbst: Thrilled to host the lung interspore meeting
Roy Herbst, Chief of Medical Oncology at Yale University, shared a post on X: "Thrilled…
Jun 23, 2024, 10:44 |
Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 22, 2024, 03:29 |
Insight
Triparna Sen: Celebrating 20 years of EGFR
Triparna Sen, Associate Professor at Icahn School of Medicine at Mount Sinai, posted on X: “Had…
Jun 21, 2024, 13:43 |
Insight
Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy
Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…
Jun 16, 2024, 12:44 |
Insight
Mara Antonoff: Dr Heather Wakelee clarifies the role of chemotherapy in NSCLC
Mara Antonoff, Associate Professor of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, shared on…
Jun 14, 2024, 03:39 |
Societies
Fred R. Hirsch: Great opening of Lung SPORE meeting
Fred R. Hirsch, Director at the Center for Thoracic Oncology at Mount Sinai Hospital, shared…
Jun 13, 2024, 15:48 |
Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 10, 2024, 09:53 |
Blog
We are proud to be members of Lung Cancer Europe - Oncogene Cancer Research
Oncogene Cancer Research recently shared a post by Lung Cancer Europe on LinkedIn, adding: "We…
Jun 1, 2024, 21:10 |
Blog
LUNGevity Foundation - Subcutan injection or IV infusion for EGFR + NSCLC
LUNGevity Foundation shared a post on X: "Subcutan injection or IV infusion? Does it matter? Phas…
May 30, 2024, 11:55 |
Blog
Pankaj Kumar Panda: Enriching interactive MTB webinar on First line management of EGFR mutated NSCLC
Pankaj Kumar Panda, Clinical Researcher at National Cancer Centre Singapore, shared a post on X: "Join…
May 29, 2024, 09:22 |
Blog
Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"
Eric K. Singhi reshared his previous post on X and added: ; "But…
May 29, 2024, 04:59 |
Blog
Estela Rodriguez: Patients excluded from most clinical trials does not help us find solutions with Leptomeningeal disease
Estela Rodriguez shared a post by EGFR Resisters on X/Twitter: "Leptomeningeal disease - is one of…
May 24, 2024, 14:15 |
Blog
ACS Journal Cancer Editor-in-Chief, Suresh S. Ramalingam, is sharing the primary results of the phase 3 LAURA trial at ASCO
ACS Journal Cancer shared the following on X: “Our Editor-in-Chief, Suresh S. Ramalingam, is sharing the…
May 20, 2024, 07:20 |
Insight
Florez Lab: ACS Journal Cancer highlights the Florez Lab's Pregnancy and Lung Cancer Registry
Florez Lab shared a post by ACS Journal Cancer, on X "Thank you to ACS…
May 19, 2024, 14:53 |
Insight
Sergio Cifuentes Canaval: KN 189 and 407 - Pooled Analysis of Outcomes
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared on LinkedIn: "KN 189…
May 19, 2024, 05:29 |
Blog
Eric Singhi: With FLAURAishing new frontline combination therapies for EGFR and metastatic NSCLC yet incomplete data
Eric Singhi shared on X: "With FLAURAishing new frontline combination therapies for EGFR and metastatic…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 14, 2024, 16:28 |
Blog
Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute…
Apr 22, 2024, 13:13 |
Blog
Fantastic to have our Co-founders Yvonne Diaz and Jan Clark attend BTOG24 in Belfast this week - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: “Fantastic to have our Co-founders Yvonne Diaz…
Apr 21, 2024, 21:21 |
Insight
Mainak Bardhan: Miami Cancer Institute Research Precision Oncology symposium 2nd Annual at The Ritz Carlton spearhead by one and only Manmeet Ahluwalia
Mainak Bardhan, Chief Scientific Officer, Chief of Medical Oncology and Deputy Director of Miami Cancer Institute,…
Apr 16, 2024, 20:18 |
Blog
Save the Date for the 4th Annual “Living with EGFR-Mutant Lung Cancer” forum! - Dana Farber's EGFR-Mutant Lung Cancer Center
Quoting Dana Farber's EGFR-Mutant Lung Cancer Center on X/Twitter: "Save the Date: Register today for…
Apr 10, 2024, 08:56 |
Career
Pasi Jänne was recently recognised with the ACS 2024 Medal of Honour Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Pasi Jänne, senior vice president for Translational…
Mar 31, 2024, 08:44 |
Blog
UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…
Mar 26, 2024, 00:22 |
Opinion
Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants
Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…
Mar 4, 2024, 17:34 |
Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Jan 16, 2024, 05:48 |
Drugs
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center,…
Jan 8, 2024, 14:37 |
Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
Sep 28, 2023, 19:02 |
Blog
Joel Bervell: Messages like this are my reminder of how important it is to create content about healthcare disparities and how powerful spreading accurate information via social media can be.
May 14, 2023, 09:34 |
Drugs
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions - The ASCO Post
Quoting from ASCO Post, "Amivantamab-vmjw, an EGFR and MET bispecific monoclonal antibody, has demonstrated encouraging…
All:
31
Posts:
1 - 100
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube